SESMOS is a life sciences company, based in Edinburgh, which develops a novel integrated screening and validation process for drug discovery.


The core of the technology is based on miniaturized small molecule libraries and fully quantitative and quality controlled biophysical screening technologies from the University of Edinburgh, linked with an innovative label free biosensor chip technology from Siemens AG in Munich.

The company has secured funding and management support from Siemens and Scottish Enterprise and is currently located in the College of Science and Engineering at the University of Edinburgh, Scotland, UK. The next twelve months will see the complete process integration and subsequently first commercial screens being completed. Further development potential into proprietary drug discovery programs is high.